Sağlık Sitelerinden Haberler


        
 
Bilgi:
Etiketler:
Yazarın adı:
Yazarın soyadı:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022
This report describes adult COVID-19 hospitalization rates by race/ethnicity during SARS-CoV-2 Delta and Omicron predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=625715
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
SUPPLEMENTS: Perceived Racism and Demographic, Mental Health, and Behavioral Characteristics Among High School Students During the COVID-19 Pandemic - Adolescent Behaviors and Experiences Survey, United States, January-June 2021
Findings from the first Adolescent Behaviors and Experiences Survey
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=671172
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022
This report describes effectiveness of mRNA COVID-19 vaccination in preventing COVID-19 associated invasive mechanical ventilation and death after receiving 2 or 3 vaccine doses.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=625714
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022
This report describes the Advisory Committee on Immunization Practices' recommendation for use of the Moderna COVID-19 vaccine in adults.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=622515
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020
This report describes programmatic gains of HIV treatment during the pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=642931
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Hospitalization of Infants and Children Aged 0-4 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022
This report describes COVID-19 hospitalization rates among infants and children aged 0-4 years, including during Omicron variant predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=613117
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022
This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575231
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022
This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=603187
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022
This report describes mRNA COVID-19 vaccine effectiveness in preventing emergency department and urgent care encounters as well as hospitalizations among children and adolescents.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575259
Etiketler:


EklenmeTarihi: 24 Mayıs 2022, Salı, 12:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022
This report describes how Omicron infection resulted in high transmission among household contacts. Prevention strategies are important to reduce transmission in households.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=564942
Etiketler: